IONIQ Sciences visual overview
In News
Salt Lake City, UT, February 2, 2023 – We're delighted to unveil this visual overview...
Read More
IONIQ Sciences to Present at Biotech Showcase
In News
Salt Lake City, UT, January 5, 2023 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ Sciences to Present at BioFuture
In News
Salt Lake City, UT, October 24, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ Unveils LUNA3, Next-Generation Early-Stage Cancer Detection Platform
In News
Salt Lake City, UT, June 23, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ Presents Lung Cancer Trial Results at ATS 2022
In News
Salt Lake City, UT, May 19, 2022 – IONIQ Sciences is proud of our team members who...
Read More
IONIQ hosts Salt Lake City Mayor Mendenhall at its Office
In News
Salt Lake City, UT, May 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) was honored...
Read More
IONIQ Sciences hires Edison Group as Investor Relations Advisor
In News
Salt Lake City, UT, March 17, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today...
Read More
IONIQ Sciences announces IP acquisition and License buyout
In News
Salt Lake City, UT, March 8, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ’s breast cancer feasibility results published by IEEE
In News
Salt Lake City, UT, November 30, 2021 – In collaboration with two of our Scientific Advisors, IONIQ...
Read More
IONIQ Sciences announces Aaron B. Dorny has joined its Board of Directors
In News
IONIQ Sciences Announces the Appointment of Aaron B. Dorny to its Board of Directors Salt Lake...
Read More